AEON Biopharma, Inc. (AEON)
(Delayed Data from AMEX)
$0.96 USD
-0.01 (-1.06%)
Updated Aug 23, 2024 03:59 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for AEON Biopharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -36.63 | 9.98 | 8.20 | 0.00 | NA |
Depreciation/Amortization & Depletion | 0.10 | 0.00 | 0.00 | 0.00 | NA |
Net Change from Assets/Liabilities | -2.74 | 3.23 | 0.44 | 0.00 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | -8.55 | -14.19 | -10.14 | 0.00 | NA |
Net Cash From Operating Activities | -47.83 | -0.98 | -1.49 | 0.00 | NA |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.40 | -276.00 | 0.00 | NA |
Net Cash from Investing Activities | 0.00 | 0.40 | -276.00 | 0.00 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 278.30 | 0.00 | NA |
Issuance (Repayment) of Debt | 14.00 | 0.15 | -0.04 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 0.00 | -0.27 | 0.00 | NA |
Net Cash from Financing Activities | 14.00 | 0.15 | 277.99 | 0.00 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -33.83 | -0.43 | 0.50 | 0.00 | NA |
Cash at Beginning of Period | 40.98 | 0.50 | 0.00 | 0.00 | NA |
Cash at End of Period | 7.16 | 0.07 | 0.50 | 0.00 | NA |
Diluted Net EPS | -0.99 | 0.29 | 0.26 | NA | NA |
Fiscal Year End for AEON Biopharma, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 46.09 | -118.02 | -36.63 | 5.86 | -4.33 |
Depreciation/Amortization & Depletion | 0.05 | 0.03 | 0.10 | 0.08 | 0.00 |
Net Change from Assets/Liabilities | -2.01 | 0.10 | -2.74 | -1.29 | 4.20 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -60.85 | 109.30 | -8.55 | -41.45 | -1.44 |
Net Cash From Operating Activities | -16.72 | -8.60 | -47.83 | -36.81 | -1.57 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 260.09 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 260.09 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | -259.00 |
Issuance (Repayment) of Debt | 15.00 | 5.00 | 14.00 | 14.00 | 0.85 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 15.00 | 5.00 | 14.00 | 14.00 | -258.15 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -1.72 | -3.60 | -33.83 | -22.81 | 0.37 |
Cash at Beginning of Period | 5.16 | 5.16 | 40.98 | 40.98 | 0.07 |
Cash at End of Period | 3.44 | 1.56 | 7.16 | 18.18 | 0.44 |
Diluted Net EPS | 4.22 | -3.17 | -0.81 | 0.28 | -0.44 |